JWH-081
Chemical compound
From Wikipedia, the free encyclopedia
JWH-081 is an analgesic chemical from the naphthoylindole family, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors.[3] With a Ki of 1.2nM it is fairly selective for the CB1 subtype, its affinity at this subtype is measured at approximately 10x the affinity at CB2(12.4nM).[4] It was discovered by and named after John W. Huffman.
Legal status
- BR: Class F2 (Prohibited psychotropics)[1]
- CA: Schedule II
- DE: Anlage II (Authorized trade only, not prescriptible)
- UK: Class B
- US: Schedule I
- I-N (Poland)[2]
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.230.181 |
| Chemical and physical data | |
| Formula | C25H25NO2 |
| Molar mass | 371.480 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
JWH-081 may be neurotoxic to animals when administered in high doses.[5]
Legal status
In the United States, JWH-081 is a Schedule I Controlled Substance.[6]
As of October 2015, JWH-081 is a controlled substance in China.[7]